Cage Bio Inc.
Clinical trials sponsored by Cage Bio Inc., explained in plain language.
-
New gel shows promise for toenail fungus
Disease control CompletedThis study tested a gel called CGB-400 on 15 adults with toenail fungus. The goal was to see if the gel could clear the fungus and improve how the nails look. Participants applied the gel for up to 12 weeks, and doctors checked their nails at several visits.
Sponsor: CAGE Bio Inc. • Aim: Disease control
Last updated May 17, 2026 12:45 UTC
-
New eczema ointment shows promise in trial
Symptom relief CompletedThis study tested whether a new ointment called CGB-500, containing the drug tofacitinib, can safely improve atopic dermatitis (eczema) in people aged 12 and older. 180 participants used either the ointment or a placebo daily for 8 weeks. Researchers measured changes in skin area…
Phase: PHASE2 • Sponsor: CAGE Bio Inc. • Aim: Symptom relief
Last updated May 17, 2026 12:54 UTC
-
New eczema ointment shows promise in small trial
Symptom relief CompletedThis study tested a new ointment called CGB-500 for people aged 12 and older with atopic dermatitis (eczema). Participants applied the ointment and a comparison drug to different skin areas twice daily for four weeks. The goal was to see if CGB-500 safely reduces eczema severity.…
Phase: PHASE2 • Sponsor: CAGE Bio Inc. • Aim: Symptom relief
Last updated May 17, 2026 12:45 UTC
-
New gel shows promise for rosacea Flare-Ups
Symptom relief CompletedThis study tested a new gel called CGB-400 on 78 adults with moderate to severe rosacea (redness and bumps on the face). Half used the gel twice a day for 12 weeks, and the other half used a gel with no active ingredient. Researchers counted skin bumps and checked overall improve…
Phase: PHASE2 • Sponsor: CAGE Bio Inc. • Aim: Symptom relief
Last updated May 11, 2026 20:50 UTC